The MSSP RAF Ceiling Just Changed.
Most ACOs Don’t Know It Yet.
One formula change. Asymmetric consequences.
For years, MSSP ACOs operated under a straightforward ceiling on positive HCC adjustment: risk scores could not grow more than 3% above the baseline year. Documentation programs were calibrated to it. Coding targets were set against it.
For any ACO entering a new agreement period in PY2024 or later, that ceiling no longer applies in its prior form. CMS replaced the flat 3% cap with a segment-level demographic ceiling that moves with each ACO's own population dynamics.
A single ceiling applied uniformly across all enrolled populations. One target. Every segment, every ACO.
A dynamic, population-specific ceiling per segment. Moves with demographic acuity. Not a fixed percentage above baseline.
Applied per segment · ESRD · AGND · DIS · AGDU
The direction of impact is not uniform. If an ACO's demographic acuity grew between baseline years and PY, the new ceiling is more generous than the flat 3% cap. If demographic acuity declined — or if the ACO was already coding aggressively in the baseline period — the effective ceiling tightened materially. Two ACOs can run the same documentation program and land on opposite sides of this change.
How the cohort actually split.
Modeled across 135 mainstream MSSP ACOs entering new agreement periods in PY2024. Five LTC-centric outliers excluded (composite flat benchmark above $2,000 PMPM) to preserve comparability across the mainstream program population.
Operating under a tighter effective ceiling than the flat 3% methodology would have produced. Benchmark suppressed relative to prior rules.
Operating under a more generous ceiling than before. Demographic acuity growth between baseline years and PY created additional headroom.
Cap was never binding either way. These ACOs were not coding close enough to the ceiling under either methodology for the change to matter.
Hurt ACOs — N=39
Helped ACOs — N=46
This is not a small-ACO problem.
The hurt cohort skews large. 41% of hurt ACOs are Large (15K–40K lives) and 18% are Very Large (40K+ lives). The Very Large hurt ACOs face a median annual suppression of $23M — at scale, the formula change is a material financial event. Helped ACOs are overwhelmingly smaller, and the benefit is modest relative to the harm on the other side.
| Size Cohort | ACOs | Share | Median Impact |
|---|---|---|---|
| Hurt ACOs — N=39 | |||
| Small — under 5K lives | 2 | 5% | $(1.7M) / yr |
| Mid — 5K to 15K lives | 14 | 36% | $(2.4M) / yr |
| Large — 15K to 40K lives | 16 | 41% | $(2.3M) / yr |
| Very Large — 40K+ lives | 7 | 18% | $(23.1M) / yr |
| Helped ACOs — N=46 | |||
| Small — under 5K lives | 0 | 0% | — |
| Mid — 5K to 15K lives | 32 | 70% | +$196K / yr |
| Large — 15K to 40K lives | 14 | 30% | +$210K / yr |
| Very Large — 40K+ lives | 0 | 0% | — |
No Very Large ACO benefited from the new methodology. Every Very Large ACO affected was hurt. Among the 39 hurt ACOs, 72% carry benchmarks above $150M annually — these are not marginal programs.
The new ceiling penalizes higher-complexity ACOs.
Every hurt ACO in the cohort falls into the Mid or High HCC tier. Not a single Low HCC ACO was hurt by the methodology change. The helped cohort is overwhelmingly Mid HCC. The new formula disproportionately affects ACOs managing more medically complex populations — the ones whose benchmark integrity arguably matters most.
Hurt ACOs — HCC Tier
Helped ACOs — HCC Tier
Five ACOs lost their payout. The contract structure eliminated it.
The benchmark suppression produced by the new methodology doesn't just reduce settlement size — in five cases it eliminated it entirely. These ACOs generated real gross savings. Their clinical teams performed. Under the flat 3% cap, each would have cleared their MSR threshold and earned a shared savings payment. Under the new demographic ceiling, the suppressed benchmark moved the threshold out of reach.
Generated positive gross savings but missed MSR threshold solely due to the new ceiling methodology. Would have cleared under the flat 3% cap.
Implied lost shared savings payment across the five ACOs. Clinical performance was sufficient. Contract mechanics eliminated the payout.
Missed MSR under both methodologies, but the gap to threshold was materially widened by the new ceiling — pushed further from a payout they were already close to.
AGND drives the majority of the impact.
AGND — Aged, Not Dual-Eligible — represents the dominant attributed population for most MSSP ACOs, typically 85% or more of total attributed lives. It is also the segment where the new methodology bites hardest.
AGND segment benchmark suppressed by the new demographic ceiling relative to the flat 3% cap. AGND is the highest-lives segment for most ACOs — suppression here compounds at scale.
Only 4 of 135 ACOs saw AGND benchmark lift from the new methodology. The change is structurally unfavorable for AGND at the population level.
For every ACO that benefited in AGND, six were suppressed. In the segment that matters most by volume, the new methodology is a net negative by a wide margin.
Why AGND is the highest-risk segment under the new formula: AGND populations tend to have stable demographic acuity with meaningful HCC coding history. ACOs that coded well in baseline years built a high BY3 HCC score — which the new formula uses as the denominator in the ceiling calculation. A high BY3 HCC means a lower ceiling ratio, which means less room for HCC growth in PY before hitting the cap. Strong historical coding becomes a structural headwind under the new methodology.
Which side of this is your ACO on?
The formula change is invisible in most settlement outcomes, but it is quietly moving benchmarks in both directions. The reconstructor shows where any ACO landed in PY2024 under the current rules. A full analysis models the ceiling by segment for your specific population.
Look up your ACO → Start a Conversation →